ArticleFrontiers in pharmacology2024

Editorial: Targeting mitochondrial dysfunction for the diagnosis and treatment of Alzheimer's and cognitive-related diseases.

Manos C Vlasiou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.